Graham Anthony from BioVista gave this talk at the HPC User Forum. “We apply our systematic discovery platform to develop our pipeline of repositioned drug candidates in neurodegenerative diseases, epilepsy, oncology and orphan diseases. We use this insight to find new uses for existing drugs or drug combinations, assess their risk profile and advance them to PoC and Clinical Phase IIa/b sooner, cheaper and with a higher probability of success than has been possible to date.”